Legend Biotech Corporation

Last updated September 27, 2026

Organization details

Legal name
Legend Biotech Corporation
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Cayman Islands
Headquarters city
Somerset
Headquarters state / province
New Jersey
Headquarters country
United States
Fiscal year end
December
Ticker symbol
LEGN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001801198

Board of directors

Chief executives

Ying Huang · Chief Executive Officer
Since March 2026

Board connections

3 of this board's directors also sit on 8 other boards. 7 are in the same sector.

Network of Legend Biotech Corporation's board connections ADARx Pharmaceuticals Inc. ADARx Pharmaceuticals... BeOne Medicines Ltd. BeOne Medicines Ltd. Calidi Biotherapeutics Inc. Calidi Biotherapeutics... Exelixis Inc. Exelixis Inc. Invivyd Inc. Invivyd Inc. TCGX Acquisition Corp. TCGX Acquisition Corp. Ultragenyx Pharmaceutical Inc. Ultragenyx Pharmaceuti... Xilio Therapeutics Inc. Xilio Therapeutics Inc... Corazon (Corsee) D. Sanders Corazon (Corsee) D.... Tomas J. Heyman Tomas J. Heyman Ying Huang Ying Huang Legend Biotech Corporation
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$566,755
5 sales by 4 insiders
Date Insider Transaction Shares Price Value
Sep 29, 2026 Corazon (Corsee) D. Sanders Director Open-market sale −27,370 $9.46 $258,920
Sep 24, 2026 Patrick John Casey Director Grant or award +20,986 — —
Sep 24, 2026 Tomas J. Heyman Director Grant or award +20,986 — —
Sep 24, 2026 Darren Xiaohui Ji Director Grant or award +28,330 — —
Sep 24, 2026 Corazon (Corsee) D. Sanders Director Grant or award +20,986 — —
Sep 24, 2026 Peter Salovey Director Grant or award +28,330 — —
Sep 24, 2026 Li Mao Director Grant or award +20,986 — —
Sep 21, 2026 Santos Carlos E Officer (Chief Financial Officer) Grant or award +19,676 — —
Sep 21, 2026 Santos Carlos E Officer (Chief Financial Officer) Open-market sale −5,430 $9.14 $49,630
Sep 15, 2026 Ingrid Zhang Officer (Chief Executive Officer) Grant or award +1,131,860 — —
Aug 14, 2026 BASH ALAN Officer (Interim CEO) Grant or award +4,908 — —
Jun 30, 2026 Patrick John Casey Director Open-market sale −6,000 $14.80 $88,800
Jun 30, 2026 Ying Huang Director, Officer (Chief Executive Officer) Gift −3,382 — —
Jun 25, 2026 Ying Huang Director, Officer (Chief Executive Officer) Open-market sale −5,566 $14.78 $82,265
Mar 25, 2026 Ying Huang Director, Officer (Chief Executive Officer) Open-market sale −9,936 $8.77 $87,139

Organizations in the same sector, closest in location and size first.

Questions about Legend Biotech Corporation

Who is the CEO of Legend Biotech Corporation?

Ying Huang has been Legend Biotech Corporation's Chief Executive Officer since March 2026.

How many directors are on Legend Biotech Corporation's board?

Legend Biotech Corporation's board has 11 directors: Corazon (Corsee) D. Sanders, Darren Xiaohui Ji, Fangliang Zhang, Gareth Kung, Li Mao, Patrick John Casey, Peter Salovey, Robin Meng, Tomas J. Heyman, Ye Wang and 1 other.

Are Legend Biotech Corporation insiders buying or selling shares?

Over the last 12 months, Legend Biotech Corporation insiders made no open-market purchases and sold $566,755 of shares in 5 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="legend-biotech-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.